Correlation Between Lipella Pharmaceuticals and Eliem Therapeutics
Can any of the company-specific risk be diversified away by investing in both Lipella Pharmaceuticals and Eliem Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lipella Pharmaceuticals and Eliem Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lipella Pharmaceuticals Common and Eliem Therapeutics, you can compare the effects of market volatilities on Lipella Pharmaceuticals and Eliem Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lipella Pharmaceuticals with a short position of Eliem Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lipella Pharmaceuticals and Eliem Therapeutics.
Diversification Opportunities for Lipella Pharmaceuticals and Eliem Therapeutics
0.58 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Lipella and Eliem is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Lipella Pharmaceuticals Common and Eliem Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eliem Therapeutics and Lipella Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lipella Pharmaceuticals Common are associated (or correlated) with Eliem Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eliem Therapeutics has no effect on the direction of Lipella Pharmaceuticals i.e., Lipella Pharmaceuticals and Eliem Therapeutics go up and down completely randomly.
Pair Corralation between Lipella Pharmaceuticals and Eliem Therapeutics
Given the investment horizon of 90 days Lipella Pharmaceuticals Common is expected to generate 4.0 times more return on investment than Eliem Therapeutics. However, Lipella Pharmaceuticals is 4.0 times more volatile than Eliem Therapeutics. It trades about 0.03 of its potential returns per unit of risk. Eliem Therapeutics is currently generating about 0.03 per unit of risk. If you would invest 575.00 in Lipella Pharmaceuticals Common on August 29, 2024 and sell it today you would lose (295.00) from holding Lipella Pharmaceuticals Common or give up 51.3% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 98.59% |
| Values | Daily Returns |
Lipella Pharmaceuticals Common vs. Eliem Therapeutics
Performance |
| Timeline |
| Lipella Pharmaceuticals |
| Eliem Therapeutics |
Lipella Pharmaceuticals and Eliem Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Lipella Pharmaceuticals and Eliem Therapeutics
The main advantage of trading using opposite Lipella Pharmaceuticals and Eliem Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lipella Pharmaceuticals position performs unexpectedly, Eliem Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eliem Therapeutics will offset losses from the drop in Eliem Therapeutics' long position.| Lipella Pharmaceuticals vs. Senti Biosciences | Lipella Pharmaceuticals vs. Fennec Pharmaceuticals | Lipella Pharmaceuticals vs. Monopar Therapeutics | Lipella Pharmaceuticals vs. Akeso, Inc |
| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |